• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by Data Knights Acquisition Corp.

    11/14/23 4:59:13 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $DKDCA alert in real time by email
    NT 10-Q 1 formnt10-q.htm

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 12b-25

    NOTIFICATION OF LATE FILING

     

    (CHECK ONE): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D
      ☐ Form N-CEN ☐ Form N-CSR      

     

    Commission File Number: 001-40386
       
      For Period Ended: September 30, 2023
       
      ☐ Transition Report on Form 10-K
      ☐ Transition Report on Form 20-F
      ☐ Transition Report on Form 11-K
      ☐ Transition Report on Form 10-Q
      ☐ Transition Report on Form N-SAR
      For the Transaction Period Ended: ______________

     

    READ INSTRUCTION (ON BACK PAGE) BEFORE PREPARING FORM. PLEASE PRINT OR TYPE.

    NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS VERIFIED ANY INFORMATION CONTAINED HEREIN.

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

    PART I - REGISTRANT INFORMATION

     

    OneMedNet Corporation
    Full Name of Registrant
     
     
    Former Name if Applicable
     
    6385 Old Shady Oak Road, Suite 250
    Address of Principal Executive Office (Street and Number)
     
    Eden Prairie, MN 55344
    City, State and Zip Code

     

     

     

     
     

     

    PART II - RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

      (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
    ☒   (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
      (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III - NARRATIVE

     

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion

    thereof, could not be filed within the prescribed time period.

     

    OneMedNet Corporation (the “Company”) has determined that it is unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2023 (the “Q3 2023 Form 10-Q”) by the prescribed due date because the Company is in the process of preparing the financial statements for the fiscal quarter ended September 30, 2023 and will need additional time to complete such financial statements and to obtain the necessary review of the Q3 2023 Form 10-Q. The Company anticipates that it will file its Q3 2023 Form 10-Q within the five-day grace period provided by Rule 12b-25 of the Securities Exchange Act of 1934, as amended.

     

    PART IV – OTHER INFORMATION

     

    (1) Name and telephone number of person to contact in regard to this notification

     

    Paul J. Casey   800   918-7189
    (Name)   (Area Code)   (Telephone Number)

     

    (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes ☐ No
     
    (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☐Yes ☒ No
     
      If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

     
     

     

    OneMedNet Corporation
    (Name of Registrant as Specified in Charter)
     
    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: November 14, 2023 By: /s/ Paul J. Casey
        Chief Executive Officer

     

     

     

    Get the next $DKDCA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DKDCA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DKDCA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • OneMedNet Network Expands with New Partnership with Large Academic Research Medical Center to Benefit its Life Science Company Clients

      ~ Partnership To Leverage Real World Data for Life Science Innovation Accelerating New Diagnostic and Treatment Solutions ~MINNEAPOLIS, MN / ACCESSWIRE / November 9, 2023 / OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet"), the leading curator of regulatory-grade imaging Real World Data ("RWD"), today announced a new partnership with a leading research medical center to accelerate and expand development of new diagnostic and treatment solutions using OneMedNet's iRWD™. Life Science innovators, including pharmaceutical, AI, medical device, and clinical research organizations, are now able to effectively use existing real world data for discovery, development, regulatory-approval, and post-mar

      11/9/23 4:15:00 PM ET
      $DKDCA
      $ONMD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • OneMedNet Completes Business Combination with Data Knights Acquisition Corp. to Become a Publicly Traded Company

      OneMedNet Common Stock to Trade on Nasdaq Under Ticker "ONMD" Tomorrow, Wednesday, November 8, 2023OneMedNet to Fully Embark on its Growth Strategy as it Spearheads the Imaging RWD Solution in the $400 Billion Clinical MarketMINNEAPOLIS, MN / ACCESSWIRE / November 7, 2023 / OneMedNet Corporation (NASDAQ:DKDCA)(NASDAQ:DKDCW) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Imaging Real World Data ("RWD"), through its proven OneMedNet iRWD™ solution, today announced that it has completed its previously announced business combination with Data Knights Acquisition Corp. ("Data Knights"). The business combination was approved at a special meeting of Data Knights' stockholde

      11/7/23 2:00:00 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination

      MINNEAPOLIS, MN and LONDON, UK / ACCESSWIRE / October 12, 2023 / Data Knights Acquisition Corp. ("Data Knights" or the "Company") (NASDAQ:DKDCU, DKDCA, DKDCW))), a special purpose acquisition company, today announced that on October 10, 2023 it caused to be deposited $75,000 into the Company's trust account, allowing the Company to extend the period of time it has to consummate its initial business combination by one month from October 11, 2023 to November 11, 2023 (the "Extension"). The Extension is the third of nine (9) one-month extensions permitted under the Company's governing documents. Cautionary Statement Regarding Forward-Looking StatementsThis press release contains statements

      10/12/23 4:45:00 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $DKDCA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Casey Paul claimed ownership of 599,172 shares (SEC Form 3)

      3 - OneMedNet Corp (0001849380) (Issuer)

      11/15/23 4:18:48 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • New insider Kosasa Thomas claimed ownership of 4,952,409 shares (SEC Form 3)

      3 - OneMedNet Corp (0001849380) (Issuer)

      11/15/23 2:08:21 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form 4: Owl Creek Asset Management, L.P. disposed of $5,175,450 worth of shares (465,000 units at $11.13)

      4 - Data Knights Acquisition Corp. (0001849380) (Issuer)

      8/21/23 6:18:49 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $DKDCA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Data Knights Acquisition Corp. (Amendment)

      SC 13G/A - OneMedNet Corp (0001849380) (Subject)

      2/14/24 6:03:43 AM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form SC 13G/A filed by Data Knights Acquisition Corp. (Amendment)

      SC 13G/A - OneMedNet Corp (0001849380) (Subject)

      2/5/24 1:55:23 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form SC 13G filed by Data Knights Acquisition Corp.

      SC 13G - Data Knights Acquisition Corp. (0001849380) (Subject)

      4/11/23 12:00:45 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $DKDCA
    Leadership Updates

    Live Leadership Updates

    See more
    • OneMedNet Appoints Healthcare IT Executive, Aaron Green, as President

      ~ Signaling a New Chapter of Growth for the Innovative Solution of Real World Data~MINNEAPOLIS, MN / ACCESSWIRE / May 23, 2023 / OneMedNet Corporation ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Imaging Real Word Data, through its proven OneMedNet iRWD™ solution, today announced the expansion of its executive team with the appointment of healthcare technology veteran, Aaron Green, as President. In this new role, Green will be responsible for all the major growth functions and lead engagement with existing clients, new clients, sales operations, marketing, communications, and product innovation, reporting directly to the CEO.Green is a healthcare technology busines

      5/23/23 4:05:00 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $DKDCA
    SEC Filings

    See more
    • Data Knights Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - OneMedNet Corp (0001849380) (Filer)

      2/9/24 4:15:31 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form S-1 filed by Data Knights Acquisition Corp.

      S-1 - OneMedNet Corp (0001849380) (Filer)

      12/18/23 8:29:14 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Data Knights Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - OneMedNet Corp (0001849380) (Filer)

      11/22/23 5:30:12 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care